The Global Leukodystrophy Initiative
Home Contact
Participate
About GLIA-CTN Leadership Core Groups Investigators Locations Projects
Advocacy Partners Research Partners
2018 H-ABC Family Conference 2022 GLIA Scientific Meeting and Advocacy Workshop 2025 GLIA Scientific Meeting and Advocacy Workshop
Data/Samples
Home Clinical Trials Network About GLIA-CTN Leadership Core Groups Investigators Locations Projects Consortium Advocacy Partners Research Partners Events 2018 H-ABC Family Conference 2022 GLIA Scientific Meeting and Advocacy Workshop 2025 GLIA Scientific Meeting and Advocacy Workshop Resources Data/Samples Contact
The Global Leukodystrophy Initiative
The Global Leukodystrophy Initiative
Participate
Example Blog Post
Example Blog Post

This is an example blog post excerpt.

Read More
Omar SherbiniOctober 31, 2017
Example Blog Post
Example Blog Post

This is an example blog post excerpt.

Read More
Omar SherbiniOctober 31, 2017

The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). GLIA-CTN is funded under grant number U54NS115052 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). The content of this website is solely the responsibility of the GLIA-CTN Administrative Core at the Children’s Hospital of Philadelphia, and does not necessarily represent the official views of the NIH.

© 2022 Global Leukodystrophy Initiative (GLIA)

GLIA-CTN Administrative Hub
3615 Civic Center Blvd. ARC516H
Philadelphia, PA 19104

Powered by:
Squarespace

GLIA-CTN Info

Mission
Leadership
Investigators
Projects
Sites

GLIA INFO

Advocacy Partners
Research Partners

Sign up to receive news and updates.

Thank you!